Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 9.8% ($ weighted) with an average mark-up of 1.8% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In January, 23% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 48% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: November 30th, 2025 Reporting Period

9.8%

Appreciation/Depreciation of All Reported Holdings1

1.8%

Average Mark-Up/Mark-Down Across All Reported Holdings2
xAI
78.3%
Redwood Materials
59.1%
Conformal Medical
47.3%
Treeline Bio
35.4%
KoBold Metals
32.6%
Revolut
31.7%
Zipline
29.9%
Databricks
25.9%
EndeavorBio
24.9%
Socure
24.2%
Fabletics
23.5%
JUUL
23.2%
FogPharma (Parabilis)
20.6%
Triveni Bio
20.0%
Oura Health
19.8%
Cardurion
18.7%
Deep Genomics
18.6%
Lime
17.9%
Sonoma Bio
17.2%
Stripe
16.7%
Cellanome
14.1%
Neurona Therapeutics
14.1%
Xsight Labs
14.0%
Quell
13.9%
Bright Peak
13.8%
Fanatics
13.7%
Element Labs
13.1%
Skyhawk
12.9%
Crusoe Energy
12.5%
Diamond Foundry
11.7%
Menlo Micro
10.9%
Cleerly
10.8%
Generate Bio
10.0%
goPuff
9.9%
Ankyra
9.7%
Mirador Therapeutics
9.7%
Runway AI
9.7%
Castle Creek
9.4%
Insitro
9.3%
City Therapeutics
9.2%
AgomAb Therapeutics
8.5%
Kartos Therapeutics
7.7%
Druva
7.5%
Waymo
7.5%
Evozyne
7.1%
Algolia
6.6%
Odyssey Therapeutics
6.3%
Locus Robotics
6.2%
Candid
6.1%
Tory Burch
5.8%
Caidya (dMed)
4.9%
Anduril
4.3%
Nuro
4.3%
VAST Data
4.3%
Asimov
3.3%
PsiQuantum
3.2%
Wugen
3.2%
Discord
2.8%
Arctic Wolf
2.4%
HaulHub
1.4%
Moloco
1.2%
Sila Nano
1.2%
Celestial AI
0.9%
Tarana
0.9%
Tenstorrent
0.9%
GOAT
0.7%
Honor Tech
0.7%
Thriveworks
0.7%
Medical Micro
0.4%
Lightmatter
0.1%
Unqork
0.1%
A24 Films
0.0%
Altos Labs
0.0%
Anthropic
0.0%
Atom Tickets
0.0%
Canva
0.0%
DataRobot
0.0%
Epirus
0.0%
Galvanize
0.0%
Kardium
0.0%
LifeMine
0.0%
Long Wall (ABL Space)
0.0%
PrognomIQ
0.0%
RefleXion Medical
0.0%
Savage X
0.0%
SecurityScorecard
0.0%
Snyk
0.0%
SpaceX
0.0%
Tanium
0.0%
T-Knife
0.0%
VideoAmp
0.0%
Cross River
-0.2%
Freenome
-0.3%
Rappi
-0.4%
Bolt
-0.6%
Skyryse
-0.6%
Dragonfly Therapeutics
-0.8%
Color Genomics
-1.4%
YuLife
-2.1%
Akeana
-2.5%
Verily
-2.7%
Genesis Therapeutics
-3.0%
Bombas
-3.4%
SiMa ai
-3.5%
Rapyd
-3.8%
Alif Semi
-4.0%
Magic Leap
-4.6%
Gusto
-4.7%
Bytedance
-5.1%
Insightec
-5.4%
Astranis
-6.1%
Ant Group
-7.1%
Empower Semi
-7.5%
Starling Bank
-7.5%
Blink Health
-7.9%
Adimab
-8.3%
Aledade
-8.4%
ElevateBio
-8.6%
CelLink
-8.9%
Epic Games
-9.1%
Goop
-9.6%
Dataminr
-9.8%
Roofstock
-9.8%
GupShup
-9.9%
Laronde
-10.0%
Element Bio
-12.7%
Tipalti
-13.0%
Superhuman (Grammarly)
-13.7%
DNA Script
-14.1%
Checkr
-14.7%
Einride
-15.1%
Applied Intuition
-15.3%
Farmers Business Network
-15.3%
Signifyd
-17.7%
Jumo
-20.3%
Asapp
-23.8%
MasterClass
-28.8%
Enevate
-35.7%
FLEXE
-36.5%
Resilience
-40.4%
SambaNova
-46.1%
Faraday Pharma
-86.0%
Rad Power
-100.0%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 9.8% ($ weighted) with an average mark-up of 1.8% (equal weighted).

xAI experienced the most significant mark-up, followed by Redwood Materials, Conformal Medical and Treeline Bio. Media & Entertainment, AI & Machine Learning, and Fintech saw the largest mark-ups across sectors.

Rad Power experienced the most significant mark-down as funds wrote off their positions. Faraday Pharma, SambaNova and Resilience also experienced significant mark-downs. Among sectors, EdTech, AgTech and PropTech saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Cerebras7+155.60%
Freenome1+109.70%
Anduril4+104.10%
SpaceX7+101.80%
VAST Data3+101.70%
Anthropic4+90.20%
Applied Intuition2+67.00%
Stripe7+49.90%
Blink Health1+49.10%
Checkr1+38.30%
OpenAI3+36.80%
Crusoe Energy2+34.50%
Moloco1+32.40%
Canva4+16.50%
Algolia1+15.00%
Dataminr1+14.40%
Discord2+13.80%
xAI7+13.40%
SambaNova1+12.70%
Groq2+12.50%
Revolut4+9.50%
Databricks3+6.40%
Bytedance4+5.20%
Gusto2+5.00%
Waymo2+4.80%
Lightmatter1+2.90%
Bolt1-0.80%
Astranis2-4.00%
PsiQuantum3-4.70%
goPuff1-11.30%
Superhuman (Grammarly)1-12.20%
Redwood Materials3-13.20%
Einride1-24.00%
KoBold Metals1-27.00%
Fanatics1-28.80%
Epic Games2-32.60%
Arctic Wolf2-33.10%
Zipline7-39.20%
Oura Health2-47.10%
Snyk1-58.30%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In January, 23% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 48% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Cerebras, Freenome, Anduril and SpaceX had the highest positive variance in reported marks versus ZX Index Values. Snyk, Oura Health, Zipline and Arctic Wolf had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
PrognomIQ.61$0.08$0.32$0.07
Nuro.50$7.96$15.29$5.48
Resilience.44$4.99$16.07$3.97
DNA Script.40$167.89$199.05$19.50
Superhuman (Grammarly).40$14.80$25.31$11.54

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, PrognomIQ ($0.07 - $0.32) saw the highest share price variance across funds followed by Nuro ($5.48 - $15.29) and Resilience ($3.97 - $16.07).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Druva
7
Candid
4
Evozyne
4
Zipline
4
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Epic Games, Gusto
8
Bolt
7
Bytedance
4
Checkr
4

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Druva saw its first positive reversal in seven quarters while Candid, Evozyne and Zipline all saw their first positive reversals in four quarters. Epic Games and Gusto saw their first negative reversals in eight quarters while Bolt saw its first negative reversal in seven quarters.

Disclaimer

This report is based on data reported by 300+ funds and $75+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right